Proceeds from collaborators Proceeds from Collaborators Shares of common stock in connection with securities purchase agreements Shares of Common Stock to be Purchased by Common Stock Warrants Shares of Common Stock to be Purchased by Common Stock Warrants Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Pay vs Performance Disclosure [Line Items] Accrued expenses Total accrued expenses Accrued Liabilities, Current Payments for loan acquisition costs Payments of Loan Costs Statistical Measurement [Domain] Statistical Measurement [Domain] Statistical Measurement [Domain] Lincoln Park Agreement, Commitment Share Lincoln Park Agreement, Commitment Share [Member] Lincoln Park Agreement, Commitment Share Research and development Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Interest and other income (expense), net Interest And Other Income, Net Interest And Other Income, Net Loans payable Increase (Decrease) In Finance Lease, Loans Payable Increase (Decrease) In Finance Lease, Loans Payable Revenue Revenue from External Customers by Products and Services [Table Text Block] Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Unvested, at beginning of period (in shares) Unvested, at end of period (in shares) Unvested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Remaining lease term Lessee, Operating Lease, Remaining Lease Term 12.5% Senior Secured Notes and Loans Payable Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Exercise of warrants (in shares) Class of Warrant or Right, Warrants Exercised The number of class of warrant or right exercised. Accrued distribution expenses and sales returns provision Accounts Receivable Allowances and Accruals, Accounts Payable and Accrued Expenses For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within Accounts payable and other accrued expenses. Royalty receivable Cumulative Royalty Receivable Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date. Number of guaranteed royalty payments Number Of Guaranteed Royalty Payments Number Of Guaranteed Royalty Payments MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Performance Shares Performance Shares [Member] Accounts payable Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Royalty Obligation Activity Royalty Obligation Activity [Table Text Block] Royalty Obligation Activity Number of cases pending Loss Contingency, Pending Claims, Number Changes in Allowance for Bad Debt Financing Receivable, Current, Allowance for Credit Loss [Table Text Block] Contingencies (Note 19) Commitments and Contingencies At-the-market offering At The Market Offering [Member] At The Market Offering Insider Trading Policies and Procedures [Line Items] Exercisable at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Restricted Stock Units Awards Nonvested Restricted Stock Shares Activity [Table Text Block] Computer, network equipment and software Computer, Network Equipment and Software [Member] Assets which are related to computer, network equipment and software. Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Geographical [Axis] Geographical [Axis] Loans payable, current Loans Payable, Current Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Taxes Income Tax Disclosure [Text Block] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate 2027 and thereafter Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter Vested restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Concentration Risk [Line Items] Concentration Risk [Line Items] Elective redemption percentage of debt Elective redemption percentage of debt Elective redemption percentage of debt. Customer [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Senior secured notes due 2025 - first additional offering First Additional Offering [Member] The first additional offering of the loan agreement. Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Diluted (in dollars per share) Earnings Per Share, Diluted Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Eighth Month Eighth Month [Member] Eighth Month PEO Total Compensation Amount PEO Total Compensation Amount Vested restricted stock units APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Vested or expected to vest at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Litigation Case [Axis] Litigation Case [Axis] Options Exercised Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Liability related to the sale of future revenue, net at December 31, 2022 Liability related to the sale of future revenue, net (includes current portion of $985) Liabilities, Sale of Future Royalties Liabilities, Sale of Future Royalties Premium on early retirement of debt Premiums Paid, Early Retirement of Debt Premiums Paid, Early Retirement of Debt Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Fair value of put option Long-Term Debt, Fair Value Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Net income (loss) Net income (loss) Net Income (Loss) Total current liabilities Liabilities, Current Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Machinery Machinery and Equipment [Member] Right-of-Use Assets and Lease Obligations Lessee, Operating Leases [Text Block] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Number of annual royalty payments receivable Number of Annual Royalty Payments Receivable Number of annual royalty payments receivable by the entity for the use of its rights and property by another party. Liabilities and stockholders’ deficit Liabilities and Equity [Abstract] Entity Ex Transition Period Entity Ex Transition Period Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Employee stock purchase plan (ESPP) Employee Stock [Member] Private equity Private equity [Member] Private equity Stockholders’ deficit: Equity, Attributable to Parent [Abstract] Other Other Assets, Miscellaneous, Noncurrent Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Contract liabilities Contract with Customer, Liability Options exercises (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Warrants issued to purchase common stock (in shares) Class Of Warrant Or Right Warrants Issued During Period The number of warrants issued during the period. Net proceeds Net Proceeds After Placement Agent Fees, Expenses, and Offering Expenses Payable Net Proceeds After Placement Agent Fees, Expenses, and Offering Expenses Payable Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Manufacture and supply Cost of Goods and Services Sold Executive Category: Executive Category [Axis] Number of Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Automatic renewal period of agreement Automatic Renewal Period of Agreement Period for which the agreement is renewed automatically. Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Name Measure Name Purchased patent Patents [Member] Name Forgone Recovery, Individual Name Vested and expected to vest at end of period (in dollars per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date Fair Value The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date. Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Warrants [Abstract] Warrants Liability [Abstract] Warrant exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Fair value of warrants issued Adjustments to Additional Paid in Capital, Fair Value of Warrants Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of fair value of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. 2025 Long-Term Debt, Maturity, Year Two Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Balance at December 31. 2022 Balance at March 31, 2023 Accounts Receivable Allowances and Accruals For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible and accruals. Local Phone Number Local Phone Number Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Remainder of 2023 Long-Term Debt, Maturity, Remainder of Fiscal Year Receivables Accounts Receivable [Member] Warrants on common shares outstanding Warrant [Member] Lease liabilities Operating Lease, Liability, Noncurrent Company Overview and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Restricted stock units Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Class of Warrant or Right [Table] Class of Warrant or Right [Table] Payments for stock issuance costs Payments of Stock Issuance Costs Depreciation Depreciation Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Indivior Commercial exploitation agreement with Indivior Commercial Exploitation Agreement with Indivior [Member] The commercial exploitation agreement with Indivior. Income Statement Location [Axis] Income Statement Location [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Unamortized deferred debt issuance cost and deferred debt discounts Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Share-based Compensation expenses [Abstract] Share-Based Payment Arrangement, Noncash Expense [Abstract] Operating Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Accounts Receivable Allowances and Accruals [Roll Forward] Accounts Receivable Allowances and Accruals [Roll Forward] Accounts Receivable Allowances and Accruals Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Aggregate payment Revenues Payables and Accruals [Abstract] Payables and Accruals [Abstract] Product and Service [Domain] Product and Service [Domain] Accrued Expenses Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Cash and cash equivalents: Restricted Cash and Cash Equivalents [Abstract] Inventories, net Increase (Decrease) in Inventories Research and development Research and Development Expense [Member] First 7 Months First Seven Months [Member] First Seven Months Investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Proprietary product sales, net Proprietary Product Sales [Member] The aggregate revenue generated from proprietary product sales. Antidilutive securities excluded from computation of earnings per share, amount (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Document Quarterly Report Document Quarterly Report Pro rata portion of target bonus Pro Rata Portion of Target Bonus Pro Rata Portion of Target Bonus Premium paid to retire debt Premium paid to retire debt Payment for Debt Extinguishment or Debt Prepayment Cost Interest expense Interest expense Interest Expense Unrecognized compensation costs of RSU awards Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Selling, general and administrative General and Administrative Expense [Member] Property and equipment, gross Property, Plant and Equipment, Gross Expected amortization Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Trading Arrangement: Trading Arrangement [Axis] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount License and royalty revenue License and Royalty Revenue [Member] The aggregate revenue generated from licensing and royalties. Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Liability related to the sale of future revenue, net Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Lease liabilities, current Operating Lease, Liability, Current Manufacture and supply revenue Manufacture and Supply Revenue [Member] The aggregate revenue generated from manufacture and supply. 2026 Long-Term Debt, Maturity, Year Three Agreement term Agreement Term Agreement Term Shares issued under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Amortization expense Amortization of Intangible Assets Entity Shell Company Entity Shell Company 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Intangible assets, net Intangible assets, net Finite-Lived Intangible Assets, Net Restatement Determination Date Restatement Determination Date Counterparty Name [Domain] Counterparty Name [Domain] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Periodic payment, principal Debt Instrument, Periodic Payment, Principal Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Less: accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Percentage of cash proceeds Repurchase Offer, Percentage of Cash Proceeds Received Repurchase Offer, Percentage of Cash Proceeds Received 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Trade receivables Accounts Receivable, before Allowance for Credit Loss Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Variable lease expense Variable Lease, Cost Operating lease expense Operating Lease, Cost Costs of common stock issued under public equity offering Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs Common stock, shares issued (in shares) Common Stock, Shares, Issued Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Inducement equity, common stock options granted (in shares) Inducement Equity, Common Stock Options Granted, Shares Inducement Equity, Common Stock Options Granted, Shares Option Indexed to Issuer's Equity, Type [Domain] Option Indexed to Issuer's Equity, Type [Domain] Severance costs Severance Costs Deferred revenue, current Contract with Customer, Liability, Current Research and development, project duration Research and Development, Project Duration Research and Development, Project Duration Security Exchange Name Security Exchange Name Long-term debt Total Long-Term Debt Consulting fee (in dollars per month) Consulting Fee Consulting Fee Interest expense related to the sale of future revenue, net Interest Expense, Sale of Future Revenues Interest Expense, Sale of Future Revenues Minimum annual royalty receivable Minimum Annual Royalty Receivable Minimum annual royalty receivable by the entity for the use of its rights and property by another party. Consideration received on sale of stock Sale of Stock, Consideration Received on Transaction Selling, general and administrative Selling, General and Administrative Expense 2027 Long-Term Debt, Maturity, Year Four Material Agreements Collaborative Arrangement Disclosure [Text Block] Stock options Employee Stock Option [Member] Interest expense related to the sale of future revenue, net Interest expense related to the sale of future revenue Interest Expense, Sale of Future Revenues (Excluding Amortization) Interest Expense, Sale of Future Revenues (Excluding Amortization) Unrecognized compensation cost, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Total costs and expenses Costs and Expenses Maximum Maximum [Member] Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Document Type Document Type Loans payable, net Loans Payable, Noncurrent Tabular List, Table Tabular List [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One License & Supply Agreement License & Supply Agreement [Member] License & Supply Agreement Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Subsequent Event [Table] Subsequent Event [Table] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Warrants Warrants Disclosure [Text Block] The entire disclosure for warrants. Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Other, net Other Noncash Income (Expense) Senior secured notes due 2025 - second additional offering Second Additional Offering [Member] The second additional offering of the loan agreement. Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Real estate and personal property taxes Taxes Payable, Current Subsequent event Subsequent Event [Member] Supplemental agreement with Indivior Supplemental Agreement with Indivior [Member] The supplemental commercial exploitation agreement with Indivior. Customer concentration risk Customer Concentration Risk [Member] Components of Identifiable Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Common stock issued (in shares) Stock Issued During Period, Shares, New Issues Title of 12(b) Security Title of 12(b) Security Litigation settlement, amount awarded from other party Litigation Settlement, Amount Awarded from Other Party Warrants and Rights Note Disclosure [Abstract] Warrants and Rights Note Disclosure [Abstract] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Sale of Future Revenue [Roll Forward] Sale of Future Revenue [Roll Forward] Sale of Future Revenue Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Royalty Interest Percent Interest Royalty Interest Percent Interest Royalty Interest Percent Interest Right to sell common stock, value Right to Sell Common Stock, Value Right to Sell Common Stock, Value Unvested, at beginning of period (in dollars per share) Unvested, at end of period (in dollars per share) Unvested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value License agreement term License Agreement Term License agreement term period. Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Sales Related Allowances and Accruals Sales Related Allowances and Accruals [Table Text Block] Tabular disclosure of valuation of sales allowance and accruals for receivables due a company that are expected to be uncollectible including a rollforward of the balance. Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Trade and Other Receivables, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Inventories, net Total inventory, net Inventory, Net Proceeds from common stock issued under private equity offering, net Proceeds from Issuance of Private Placement Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Axis] Payments / credits Accounts Receivable Allowances, Credits and payments For an unclassified balance sheet, a valuation of sales allowance for receivables related to credits due a company that are expected to be uncollectible. Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] MAM Pangolin Royalty , LLC Marathon Pangolin Royalty LLC [Member] Marathon Pangolin Royalty LLC Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Debt repaid, principal Debt Instrument, Repaid, Principal Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Forfeited/expired (in dollars per share) Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Forfeitures And Expirations In Period WeightedAverageExercisePrice Weighted average price of options that were either exercised, forfeited or expired. Revenue Recognition and Performance Obligations Revenue from Contract with Customer [Policy Text Block] Principal amount Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Counterparty Name [Axis] Counterparty Name [Axis] License agreement with Sunovion Pharmaceuticals, Inc. upfront License Agreement with Sunovion Pharmaceuticals, Inc. Upfront [Member] The license agreement made with sunovion pharmaceuticals, inc. advance payments. Public equity Public equity [Member] Public equity Operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Expected amortization in 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Issuance [Axis] Issuance [Axis] Issuance Share-based Compensation Expense Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Senior secured notes due 2025 Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member] A debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer. Cardinal Cardinal [Member] Cardinal Trade and other receivables, net Increase (Decrease) in Accounts and Other Receivables PEO PEO [Member] Other Stockholders' Equity, Other Number of leases Number of Operating Leases Number of operating leases. Lincoln Park agreement Lincoln Park Agreement [Member] Lincoln Park Agreement Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Royalty Payment Term Royalty Payment Term Royalty Payment Term Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Net cash used for investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Inventory, Net Schedule of Inventory, Current [Table Text Block] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Repayment of debt Repayments of Debt Total operating lease liabilities Operating Lease, Liability Credit Facility [Axis] Credit Facility [Axis] Debt Maturity Schedule of Maturities of Long-Term Debt [Table Text Block] Total liabilities Liabilities Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Exercisable at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] All Executive Categories All Executive Categories [Member] Deferred revenue Contract with Customer, Liability, Noncurrent Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Earnings (loss) per share attributable to common stockholders: Earnings Per Share [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Trade and other receivables, net Trade and other receivables, net Trade and other receivables, net Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables). Common stock, $0.001 par value. Authorized 250,000,000 shares; 66,740,765 and 54,827,734 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Repurchase price percentage Debt Instrument, Redemption Price, Percentage Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Manufacture and supply Manufacturing and supply [Member] Primary financial statement caption encompassing Manufacturing and supply expense. Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Receivable Contract with Customer, Receivable, after Allowance for Credit Loss Senior notes Senior Notes [Member] Total current assets Assets, Current Revenue from Contract with Customer [Abstract] All Individuals All Individuals [Member] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Litigation Case [Domain] Litigation Case [Domain] Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] PEO Name PEO Name Concentrations of risk Concentration Risk, Percentage Sale of Future Revenue Sale of Future Revenue [Text Block] Sale of Future Revenue Class of warrant or right, outstanding (in shares) Class of Warrant or Right, Outstanding Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Geographic Areas, Revenues from External Customers [Abstract] Geographic Areas, Revenues from External Customers [Abstract] Packaging material Inventory Packing Material Gross Amount of packaging materials expected to be sold within one year or operating cycle, if longer. Cash payment representing 90 days of base pay Cash Payment Representing 90 Days of Base Pay Cash Payment Representing 90 Days of Base Pay Proceeds from shares issued under employee stock purchase plan Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Net cash used for operating activities Net Cash Provided by (Used in) Operating Activities Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Other Other Accrued Liabilities, Current Furniture and fixtures Furniture and Fixtures [Member] Interest rate Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Proceeds from warrant exercises Proceeds from Warrant Exercises Issuance [Domain] Issuance [Domain] Issuance Total stockholders’ deficit Beginning balance Ending balance Equity, Attributable to Parent Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Haisco Pharmaceutical Group Co., Ltd, upfront payment Haisco Pharmaceutical Group Co., Ltd, Upfront Payment [Member] Haisco Pharmaceutical Group Co., Ltd, Upfront Payment New Warrants New Warrants [Member] New Warrants Deferred revenue Increase (Decrease) in Deferred Revenue Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Duration of payment [Axis] Duration of payment [Axis] Duration of payment Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Events [Abstract] Subsequent Events [Abstract] Net income (loss) before income taxes Net (loss)/income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Additions to intangible assets Payments to Acquire Intangible Assets Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Depreciation, amortization, and impairment Depreciation, Depletion and Amortization, Nonproduction Stock issued during period, conversion of convertible securities (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Other Non-current Assets Other Assets Disclosure [Text Block] Provision Accounts Receivable Allowances, Provision (Reversal) Related to Sales For an unclassified balance sheet, a valuation of sales allowance for receivables related to sales due a company that are expected to be uncollectible. Entity Emerging Growth Company Entity Emerging Growth Company Put option Put Option [Member] Finished goods Inventory, Finished Goods, Gross Net proceeds from issuance of initial notes, warrants and first offer rights Net Proceeds from Issuance of Initial Notes, Warrants and First Offer Rights The net cash inflow associated with the amount received from issuance of initial notes, warrants and first offer rights. Effective annual interest rate Debt Instrument, Interest Rate, Effective Percentage Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title Outstanding (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based compensation Share-Based Payment Arrangement, Noncash Expense Common Stock Common Stock [Member] Individual: Individual [Axis] Material Agreements [Abstract] Material Agreements [Abstract] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Net Earnings (Loss) Per Share Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Royalty Royalty [Member] Duration of payment [Domain] Duration of payment [Domain] Duration of payment [Domain] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Minimum Minimum [Member] Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Payments for taxes on share-based compensation Payment, Tax Withholding, Share-Based Payment Arrangement Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] License agreement with Sunovion Pharmaceuticals, Inc. License Agreement with Sunovion Pharmaceuticals, Inc. [Member] The license agreement made with sunovion pharmaceuticals, inc. Contingencies Commitments and Contingencies Disclosure [Text Block] Accumulated Deficit Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders’ deficit Liabilities and Equity Other income/ (expenses): Nonoperating Income (Expense) [Abstract] Other non-current assets Total other non-current assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Basic (in dollars per share) Earnings Per Share, Basic Right-of-use assets, net Operating Lease, Right-of-Use Asset Unrecognized compensation expense related to non-vested stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Shares issued under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Sale of Stock [Domain] Sale of Stock [Domain] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Remainder 2023 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Warrants issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Existing Warrants Existing Warrants [Member] Existing Warrants Arrangement Duration Trading Arrangement Duration Summary of Other Non-current Assets Schedule of Other Assets, Noncurrent [Table Text Block] Remaining amount available for offering Sale Of Stock, Remaining Amount Available For Offering Sale Of Stock, Remaining Amount Available For Offering Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Proceeds from refinancing of debt Proceeds from Issuance of Debt Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Contract and other receivables Other Receivables, Gross, Current Purchased intangible Technology-Based Intangible Assets [Member] Termination Date Trading Arrangement Termination Date Co-development and research fees Co-Development and Research Fees [Member] The aggregate revenue generated from Co-development and research fees. Accounts payable Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Assertio Holdings, Inc Assertio Holdings, Inc [Member] Assertio Holdings, Inc Neurelis, Inc. v. Aquestive Therapeutics, Inc. Neurelis, Inc. v. Aquestive Therapeutics, Inc. [Member] Neurelis, Inc. v. Aquestive Therapeutics, Inc. Raw material Inventory, Raw Materials, Gross Forfeited/expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised,Forfeitures and Expirations in Period For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Periodic payment, interest Debt Instrument, Periodic Payment, Interest Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Effect of dilutive stock options and warrants (in shares) Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Adjustments to reconcile net loss to net cash used for operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Inducement equity, common stock options outstanding (in shares) Inducement Equity, Common Stock Options Outstanding, Shares Inducement Equity, Common Stock Options Outstanding, Shares All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] Equity distribution agreement Equity Distribution Agreement [Member] Equity Distribution Agreement Compensation Amount Outstanding Recovery Compensation Amount Additions charged to expense Accounts Receivable, Credit Loss Expense (Reversal) Additional paid-in capital Additional Paid in Capital Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Subsequent Event Type [Axis] Subsequent Event Type [Axis] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Shares of common stock Shares of Common Stock Entitled to Purchasers by Pre-funded Warrants Shares of Common Stock Entitled to Purchasers by Pre-funded Warrants Insider Trading Arrangements [Line Items] Less: allowance for doubtful accounts Allowance for doubtful accounts at beginning of the period Allowance for doubtful accounts at end of the period Accounts Receivable, Allowance for Credit Loss 2024 Long-Term Debt, Maturity, Year One Share price (in dollars per share) Share Price Severance period Severance Period Severance Period Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Effect of share-based payment arrangements (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Adjustment to Compensation, Amount Adjustment to Compensation Amount Common Stock Warrants Common Stock Warrants [Member] Common Stock Warrants Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Axis] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Proceeds from sale of future revenue Proceeds From Sale of Future Revenues, Net Proceeds From Sale of Future Revenues, Net Revenue from Contract with Customer Benchmark Revenue from Contract with Customer Benchmark [Member] Warrant exercises Warrant exercises [Member] Warrant exercises 12.5% Senior Secured Notes [Abstract] Senior Secured Notes [Abstract] Redemption percentage of debt under change of control provisions Redemption percentage of debt under change of control provisions Redemption percentage of debt under change of control provisions. Entity Central Index Key Entity Central Index Key Subsidiary or equity method investee, cumulative percentage ownership limitation after all transactions Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions Amortization of debt issuance costs and discounts Amortization expense, deferred debt issuance costs and debt discounts Amortization of Debt Issuance Costs and Discounts Risks and Uncertainties Concentration Risk Disclosure [Text Block] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Share-based compensation expenses Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Intangible assets, gross Finite-Lived Intangible Assets, Gross Income taxes Income Tax Expense (Benefit) Ex-United States Non-US [Member] Write-downs charged against the allowance Accounts Receivable, Allowance for Credit Loss, Writeoff Accrued compensation Employee-related Liabilities, Current Number of installments Number Of Installments Number Of Installments Financial Instruments – Fair Value Measurements Fair Value Disclosures [Text Block] Repayment of debt principal including lease liabilities Payments for loan acquisition costs Payments of Financing Costs Name Trading Arrangement, Individual Name Monetization Agreement Monetization Agreement [Member] Monetization Agreement Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Securities purchase agreement Securities Purchase Agreement [Member] Securities Purchase Agreement Common stock issued, value Stock Issued During Period, Value, New Issues Inventories, Net Inventory Disclosure [Text Block] Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Revenues Royalties related to the sale of future revenue Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Estimated discount rate Lessee, Operating Lease, Discount Rate Ninth through Eighteenth Month Ninth through Eighteenth Month [Member] Ninth through Eighteenth Month Finite-Lived Intangible Assets, Net [Abstract] Finite-Lived Intangible Assets, Net [Abstract] License agreement with Sunovion Pharmaceuticals, Inc milestones License Agreement with Sunovion Pharmaceuticals, Inc Milestones [Member] The license agreement made with sunovion pharmaceuticals, inc. milestones. Performance Share Activity Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Cash payments for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Days of base pay Days of Base Pay Days of Base Pay Accrued balances - trade and other receivables, net Less: sales-related allowances Accounts Receivable Allowances and Accruals, Trade and Other Receivables, Net For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net. Credit Facility [Domain] Credit Facility [Domain] Coverage duration Coverage duration Coverage duration Useful Lives Property, Plant and Equipment, Useful Life Liability related to the sale of future revenue, current Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Leasehold improvements Leasehold Improvements [Member] Diluted (in shares) Weighted-average number of common shares - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Fair value of warrants Warrants Not Settleable in Cash, Fair Value Disclosure Costs and expenses: Operating Expenses [Abstract] Revenue and Trade Receivables, Net Revenue from Contract with Customer [Text Block] Capital expenditures Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Proceeds from debt, contingent on additional milestones Contingent Monetization Agreement, Milestone Payment Contingent Monetization Agreement, Milestone Payment At-the-market offering, amendment no. 1 At The Market Offering, Amendment One [Member] At The Market Offering, Amendment One Additional Paid-in Capital Additional Paid-in Capital [Member] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] Atnahs Pharma UK Limited Atnahs Pharma UK Limited [Member] Atnahs Pharma UK Limited Additional borrowing capacity Debt Instrument, Additional Borrowing Capacity Amount of debt that can be borrowed in addition to initial notes. Subsequent Events Subsequent Events [Text Block] Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amortization of issuance costs Amortization of Debt Issuance Costs 2028 Long-Term Debt, Maturity, Year Five Current portion Liabilities, Sale of Future Royalties, Current Liabilities, Sale of Future Royalties, Current United States UNITED STATES Other non-current liabilities Other Liabilities, Noncurrent Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Thirteen Point Five, Senior Secured Notes due November 1, 2028 Thirteen Point Five, Senior Secured Notes due November 1, 2028 [Member] Thirteen Point Five, Senior Secured Notes due November 1, 2028 Non-NEOs Non-NEOs [Member] Total future lease payments Lessee, Operating Lease, Liability, to be Paid Construction in progress Construction in Progress [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Weighted average common shares outstanding: Earnings Per Share, Basic, Other Disclosure [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Basic (in shares) Weighted-average number of common shares – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Remaining Warrants Remaining Warrants [Member] Remaining Warrants Loss from operations Operating Income (Loss) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Proceeds from issuance and exercise of warrants Proceeds from Issuance and Exercise of Warrants Proceeds from Issuance and Exercise of Warrants Proceeds from common stock issued under public equity offering, net Proceeds from Issuance Initial Public Offering Vested and expected to vest at end of period (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, in Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Sale of stock, aggregate offering price Sale of Stock, Aggregate Offering Price Sale of Stock, Aggregate Offering Price Vested or expected to vest at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Reclassifications Accounts Receivable Allowances, Reclassifications Accounts Receivable Allowances, Reclassifications Atnahs Pharma UK Limited, Amended Agreement Atnahs Pharma UK Limited, Amended Agreement [Member] Atnahs Pharma UK Limited, Amended Agreement